MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
MannKind MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation…
Inhaling marijuana associated with increased odds of developing asthma
If you’re looking to reduce your chances of developing lung disease, say experts at UC San Francisco, then…